Zoetis Inc. announced Feb. 7 the acquisition of Ethos Diagnostic Science, a veterinary reference laboratory business dedicated to serving leading specialty animal hospitals, the greater veterinary community and researchers with accurate, reliable results.
Having entered the veterinary reference laboratory space through the acquisitions of both Phoenix Lab and ZNLabs in 2019, Zoetis said it continues to grow its diagnostics presence to offer comprehensive and enhanced value to veterinarians in the U.S. Financial terms of the transaction are not being disclosed.
Ethos Diagnostic Science is a business unit of Ethos Veterinary Health and has laboratory locations in Boston, Mass.; Denver, Colo., and San Diego, Cal. Ethos Diagnostic Science performs testing for all veterinary species in hematology, clinical chemistry, urinalysis, microbiology, parasitology, endocrinology, serology, cytology and histology, Zoetis said.
“We are thrilled to add the Ethos Diagnostic Science labs to our expanding diagnostics presence in the U.S., and we look forward to working with their dedicated, trusted, board-certified pathologists and laboratory technicians,” said Lisa Lee, senior vice president and head of global diagnostics for Zoetis. “With the addition of Ethos’s labs in San Diego, Denver and Boston, we continue to build a more holistic diagnostics portfolio at Zoetis, and together, we can provide veterinarians with even more valuable service and accurate insights that inform the care they provide to animals.”
According to Zoetis, reference laboratories and point-of-care diagnostic testing are highly synergistic, offering veterinarians a single source for a full spectrum of tests as well as access to the expertise of board-certified specialists and pathologists to support test results.
The global veterinary diagnostics category, which includes reference laboratory and point-of-care diagnostics, is estimated to exceed $4 billion, with compound annual growth of approximately 10% over the past three years, Zoetis said, noting that it expects the category to continue to grow faster than the overall animal health industry. This growth in the high single digits is driven by pet owners’ increasing interest in pet wellness trends, along with rising medicalization rates, increasing standards of veterinary care and the convenience of in-clinic testing, Zoetis said.
Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion and had approximately 10,000 employees.
Ethos Diagnostic Science, part of Ethos Veterinary Health, is a full-service veterinary diagnostic laboratory founded in 2015 as the former STAT Veterinary Lab.